BioPortfolio
[ Home ] [ Up ] [ Store Home Page ] [ Info ] [ Search ] [ View Basket ] [ Checkout ] [ Send email ] [ Login ]
 

The Taq Wars Competitive Intelligence on How to Survive

The Taq Wars Competitive Intelligence on How to Survive


As the engine that fuels the polymerase chain reaction (PCR), one of the most important inventions in molecular biology, Taq polymerase has transformed how life science research is conducted. This powerful technique for DNA amplification relies on the amazing processivity of DNA polymerase I enzymes from the bacterium, Thermus aquaticus (Taq polymerase). Because many of its enzymes—including Taq polymerase—are thermostable, it thrives in blistering hot environments. The thermostability of Taq polymerase is the critical feature that facilitated the development of PCR and insured its commercial success.

Since March 28, 2005, researchers no longer need a license to practice the basic PCR amplification process, which was covered by U.S. Patents 4,683,195, 4,683,202 and 4,965,188. This much anticipated opportunity has opened the door for an influx of suppliers hoping to provide Taq polymerase to scientists for this specific application. Suppliers hoping to secure market share will find The Taq Wars: Competitive Intelligence on How to Survive, a new report produced by BioInformatics, LLC, an indispensable guide to successfully selling this commodity product.

Based on a 28-question survey of over 600 researchers who use Taq DNA Polymerase, the report examines what motivates scientists to purchase Taq polymerase from one supplier over another and whether these decisions are influenced by market segment, job position and the length of time scientists have been using the enzyme. It provides insights into whether access to less expensive Taq polymerase will change scientists’ purchasing preferences. The report also presents a detailed analysis of price sensitivity and elasticity in regard to the demand for Taq polymerase in three different market segments: industrial, government and academia.

From the perspective of researchers who use Taq DNA Polymerase, the primary objectives of this report are as follows:

1. Identify the factor(s) that influence a customer’s decision to purchase one brand of Taq DNA Polymerase over another

2. Determine the frequency/likelihood for brand switching

3. Assess price sensitivity and price elasticity

4. Understand the role of customer satisfaction and brand loyalty in the purchasing decision

5. Reveal market specific differences in purchasing behavior and preferred suppliers

Publication Date: November 2005

Page Count: 124

Print Copy: $4,000

Company-wide Electronic Copy (includes print copy): $6,000



Price



Buy Biotechnology Management Reports online with BioPortfolio's secure E-Commerce portal.

Back to top